These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22607288)

  • 21. Histoid leprosy; report of three cases.
    Krishna KK
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):174-6. PubMed ID: 10472376
    [No Abstract]   [Full Text] [Related]  

  • 22. Leprosy: recognizing red flags.
    Pearce V; Horton JJ
    Australas J Dermatol; 2008 Nov; 49(4):226-8. PubMed ID: 18855787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
    Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
    Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
    Rodríguez G; Pinto R; López F; Gómez Y
    Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythema nodosum leprosum associated with minocycline.
    Travassos AR; Antunes J; Pacheco D; Almeida LS; Filipe P; Marques MS
    Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):39-41. PubMed ID: 23000940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lepromatous iridocyclitis.
    Citirik M; Batman C; Aslan O; Adabag A; Ozalp S; Zilelioglu O
    Ocul Immunol Inflamm; 2005 Feb; 13(1):95-9. PubMed ID: 15804778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Widespread Dermatophytosis in a Patient Treated for Leprosy Type II Reactional State after MDT/WHO-MB Release.
    Tavares Rodrigues F; Pereira Cardozo MR; da Costa Nery JA
    Am J Trop Med Hyg; 2018 Oct; 99(4):813-814. PubMed ID: 30292246
    [No Abstract]   [Full Text] [Related]  

  • 29. [Leprosy and the testis].
    Rodríguez G; Abaúnza MC; Vargas EJ; López F
    Biomedica; 2012; 32(1):13-22. PubMed ID: 23235783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
    Thomas A; Balakrishnan A; Nagarajan M; Prabhakar R; Tripathy SP; Christian M; Somasundaram PR
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):273-80. PubMed ID: 2198314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lucio leprosy with lucio phenomenon.
    Saoji V; Salodkar A
    Indian J Lepr; 2001; 73(3):267-72. PubMed ID: 11840599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lest we forget Hansen's disease (leprosy): an unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience.
    Sheetal S; Arvind C
    Int J Rheum Dis; 2009 Apr; 12(1):64-9. PubMed ID: 20374320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffuse Lepromatous Leprosy Due to Mycobacterium lepromatosis in Quintana Roo, Mexico.
    Han XY; Quintanilla M
    J Clin Microbiol; 2015 Nov; 53(11):3695-8. PubMed ID: 26311856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guess what! Targetoid erythematous plaques: an unusual morphological presentation of multibacillary Hansen's disease.
    Nunez-Gussman J; Hwang L; Hsu S
    Eur J Dermatol; 2001; 11(1):65-7. PubMed ID: 11174144
    [No Abstract]   [Full Text] [Related]  

  • 35. Erythema nodosum leprosum necroticans in a child--an unusual manifestation.
    Pandhi D; Mehta S; Agrawal S; Singal A
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):122-6. PubMed ID: 16830655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
    Fu X; Liu H; Zhang F
    Am J Trop Med Hyg; 2015 Aug; 93(2):207-209. PubMed ID: 26251526
    [No Abstract]   [Full Text] [Related]  

  • 37. Two atypical presentations of lepra reactions.
    Pathania V; Shelly D; Shankar P; Matharu YS; Baveja V
    Int J Mycobacteriol; 2018; 7(4):390-393. PubMed ID: 30531041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy.
    Ganapati R; Pai VV; Banerji U; Thomas J; Saha B
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):495-7. PubMed ID: 9465161
    [No Abstract]   [Full Text] [Related]  

  • 39. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M; Saunderson PR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple cold abscesses in a borderline lepromatous patient on multidrug therapy.
    Kulkarni V; Gharpuray MB; Kulkarni DS
    Indian J Lepr; 1989 Oct; 61(4):442-4. PubMed ID: 2621380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.